FDA Adverse Event Malfunction Summary report: N

INSIGNIA

MDR report key: 4131760 · Received October 1, 2014

Report

Report Number
2124215-2014-14857
Event Type
Malfunction
Date Received
October 1, 2014
Date of Event
December 29, 2009
Report Date
July 11, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE RIGHT ATRIAL (RA) LEAD AND DEVICE DISPLAYED STEADILY INCREASING PACING IMPEDANCE MEASUREMENTS OVER A SIX YEAR PERIOD, ULTIMATELY REACHING GREATER THAN 2,500 OHMS. ADDITIONALLY, SUDDEN BRADYCARDIA RESPONSE (SBR) MAXIMUM RATE ACHIEVED WAS 125BPM, HOWEVER, THE ELECTROGRAM (EGM) DISPLAYED A RATE OF 300BPM THROUGH VISUAL INSPECTION. THE PATIENT LATER ENDURED OPEN HEART SURGERY FOR VALVE REPLACEMENT. FOLLOWING THE PROCEDURE, RA PACING IMPEDANCE MEASUREMENTS REMAINED GREATER THAN 2,500 OHMS, WITH DECREASED SENSING MEASUREMENTS. ADDITIONAL INFORMATION WAS SOUGHT FROM THE LOCAL AREA SALES REPRESENTATIVE, HOWEVER, AT THIS TIME ADDITIONAL INFORMATION WAS NOT AVAILABLE. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT OF THIS CLINICAL OBSERVATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
612219 INSIGNIA IMPLANTABLE PULSE GENERATOR LWP GUIDANT CRM CLONMEL IRELAND 1294

Patients

Seq Age Sex Outcome Treatment
1 51 YR 4088| 1294| 4086